Search

everythinglearnresearchcommunity

for

Search:↓

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

m-Aminophenol in hair dye can cause skin cell toxicity and stress responses.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Early diagnosis, stopping the suspected drug, and supportive care are crucial for treating Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Adult acne severity is influenced by stress, skin sensitivity, makeup, stopping oral contraceptives, and requires female-specific treatment guidelines.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

UVB radiation harms hair growth and health, causing cell death and other changes in human hair follicles.

Pimecrolimus cream is not effective for treating alopecia areata.

γδ T cells adapt uniquely to different tissues in mice.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Pumpkin seeds may help expel parasites, but findings are retracted.

GLP-1 agonists may help treat certain skin conditions.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

No cure exists for alopecia areata, and treatments are personalized.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Myristica fragrans shows promise as an anti-inflammatory agent.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.